Trials / Conditions / Metastatic HER2 Positive Gastroesophageal Junction Cancer
Metastatic HER2 Positive Gastroesophageal Junction Cancer
4 registered clinical trials studyying Metastatic HER2 Positive Gastroesophageal Junction Cancer — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients NCT06650332 | Zhejiang Cancer Hospital | Phase 1 / Phase 2 |
| Terminated | CYNK-101 in Combination with Trastuzumab and Pembrolizumab in Patients with Locally Advanced Unresectable or M NCT05207722 | Celularity Incorporated | Phase 1 / Phase 2 |
| Unknown | A Study of MRG002 in the Treatment of HER2-positive/HER2-low Locally Advanced or Metastatic Gastric/Gastroesop NCT05141747 | Shanghai Miracogen Inc. | Phase 2 |
| Terminated | TAC T-cells for the Treatment of HER2-positive Solid Tumors NCT04727151 | Triumvira Immunologics, Inc. | Phase 1 / Phase 2 |